Quince Therapeutics, Inc.

IRLA Healthcare Biotechnology

In the quarter to June 2026, EPS grew 81.9%, free cash flow fell 63.7% and total debt rose 28.2%, each against the same quarter a year earlier.

32.17 1.06 −3.19%
Market cap
$33.8M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Total current assets
22.90 44.04 77.44 93.75 111.67 137.86 106.06 72.58 7.54
Total non-current assets
70.63 70.44 90.46 10.16 21.56 51.60 18.31 0.29 0.18
Total Assets
93.52 114.48 167.90 103.91 133.23 189.47 124.37 72.88 7.72
Total current liabilities
43.23 7.28 9.57 3.07 14.22 17.00 8.89 1.46 1.76
Total non-current liabilities
86.01 77.05 73.24 0.25 0.42 0.21 — 104.05 26.24
Total liabilities
129.24 84.33 82.82 3.32 14.64 17.20 8.89 105.50 28.00
Common Equity (Total)
(35.71) 30.15 85.08 100.59 118.59 172.26 115.48 (32.63) (20.28)
Shareholders Equity (Total)
(35.71) 30.15 85.08 100.59 118.59 172.26 115.48 (32.63) (20.28)
Total Debt
18.03 14.32 13.43 0.45 1.16 0.45 — — 7.17

Show all line items

In millions of $ except per-share values · columns are period end dates